X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (220) 220
humans (200) 200
aerosolized prostacyclin (153) 153
administration, inhalation (127) 127
hypertension, pulmonary - drug therapy (113) 113
pulmonary hypertension (109) 109
aerosolized iloprost (100) 100
female (96) 96
male (93) 93
respiratory-distress-syndrome (92) 92
nitric-oxide (83) 83
inhaled nitric-oxide (78) 78
respiratory system (77) 77
prostacyclin (76) 76
vasodilator agents - administration & dosage (69) 69
cardiac & cardiovascular systems (65) 65
middle aged (65) 65
epoprostenol - administration & dosage (63) 63
vasodilator agents - therapeutic use (63) 63
abridged index medicus (61) 61
adult (61) 61
hypertension (57) 57
iloprost (57) 57
iloprost - administration & dosage (55) 55
hypertension, pulmonary - physiopathology (54) 54
therapy (49) 49
critical care medicine (45) 45
nitric oxide (45) 45
epoprostenol - therapeutic use (44) 44
anesthesiology (43) 43
hemodynamics - drug effects (41) 41
pediatrics (40) 40
aged (38) 38
nitric oxide - administration & dosage (38) 38
treatment outcome (38) 38
acute lung injury (36) 36
animals (36) 36
arterial-hypertension (36) 36
hypertension, pulmonary - etiology (35) 35
long-term treatment (34) 34
pharmacology & pharmacy (34) 34
epoprostenol (32) 32
iloprost - therapeutic use (32) 32
inhalation (30) 30
antihypertensive agents - administration & dosage (29) 29
antihypertensive agents - therapeutic use (28) 28
nitric oxide - therapeutic use (28) 28
child (27) 27
medicine, general & internal (27) 27
drug therapy (25) 25
gas-exchange (25) 25
surgery (25) 25
vasodilators (25) 25
inhaled iloprost (24) 24
pulmonary arterial hypertension (24) 24
vascular resistance - drug effects (24) 24
vasodilator agents - pharmacology (23) 23
aerosols (22) 22
cardiac-surgery (22) 22
care and treatment (22) 22
continuous intravenous epoprostenol (22) 22
double-blind (22) 22
epoprostenol prostacyclin (22) 22
survival (22) 22
pulmonary circulation - drug effects (21) 21
acute respiratory distress syndrome (20) 20
cardiopulmonary bypass (20) 20
children (20) 20
dose-response relationship, drug (20) 20
drug therapy, combination (20) 20
medicine & public health (20) 20
oxygenation (20) 20
respiratory distress syndrome, adult - drug therapy (20) 20
vascular-resistance (20) 20
bosentan (19) 19
congenital heart-disease (19) 19
hypertension, pulmonary - diagnosis (19) 19
prostacyclin analog (19) 19
pulmonary arteries (19) 19
pulmonary-hypertension (19) 19
retrospective studies (19) 19
vasoconstriction (19) 19
adolescent (18) 18
blood pressure - drug effects (18) 18
disease (18) 18
iloprost - pharmacology (18) 18
infant, newborn (18) 18
pulmonary artery - drug effects (18) 18
sildenafil (18) 18
trial (18) 18
epoprostenol - pharmacology (17) 17
lung (17) 17
peripheral vascular disease (17) 17
prospective studies (17) 17
secondary (17) 17
transplantation (17) 17
cardiology (16) 16
infant (16) 16
vasodilator agents - adverse effects (16) 16
calcium-channel blockers (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 04/2016, Volume 67, Issue 4, pp. 290 - 298
Journal Article
Respiratory care, ISSN 0020-1324, 08/2017, Volume 62, Issue 8, pp. 1014 - 1022
Journal Article
The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 2009, Volume 138, Issue 6, pp. 1417 - 1424
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 2004, Volume 102, Issue 2, pp. 139 - 153
Prostacyclin and its analogues (prostanoids) are potent vasodilators and possess antithrombotic and antiproliferative properties. All of these properties help... 
VASODILATORY RESPONSE | ARTERIAL-HYPERTENSION | AEROSOLIZED PROSTACYCLIN | ACUTE LUNG INJURY | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | PLACEBO-CONTROLLED TRIAL | CONTINUOUS INTRAVENOUS EPOPROSTENOL | LONG-TERM TREATMENT | INHALED NITRIC-OXIDE | RESPIRATORY-DISTRESS-SYNDROME
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 1999, Volume 160, Issue 2, pp. 600 - 607
Journal Article
Chest, ISSN 0012-3692, 03/2000, Volume 117, Issue 3, pp. 819 - 827
This study was carried out to determine the efficacy of and dose-response relationships to inhaled aerosolized prostacyclin (IAP), when used as a selective... 
CO = cardiac output | ventilation/perfusion ratio | Fio2 = fraction of inspired oxygen | aerosolized prostacylin | SPV = selected pulmonary vasodilator | APACHE = acute physiology and chronic health evaluation | CI = cardiac index | RIA = radioimmunoassay | NO = nitric oxide | IAP = inhaled aerosolized prostacyclin | 6-ketoPGF1α = 6-keto prostaglandin F1α | MAP = mean arterial pressure | MPAP = mean pulmonary artery pressure | ARDS | Qs/Qt = intrapulmonary shunt fraction | P(A-a)O2 = alveolar-arterial oxygen partial pressure difference | Aerosolized prostacylin | SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | PGI | PULMONARY-HYPERTENSION | RESPIRATORY SYSTEM | NITRIC-OXIDE | VASODILATOR | FAILURE | RESPIRATORY-DISTRESS-SYNDROME | Hypoxia - drug therapy | Prospective Studies | Humans | Middle Aged | Male | Respiratory Distress Syndrome, Adult - etiology | Dose-Response Relationship, Drug | Respiratory Distress Syndrome, Adult - blood | Epoprostenol - adverse effects | Adult | Female | Platelet Aggregation - drug effects | Drug Administration Schedule | Administration, Inhalation | Treatment Outcome | Respiratory Distress Syndrome, Adult - drug therapy | Oxygen - blood | Hypoxia - blood | Aerosols | Aged | Hemodynamics - drug effects | Vasodilator Agents - adverse effects | Vasodilator Agents - administration & dosage | 6-Ketoprostaglandin F1 alpha - blood | Epoprostenol - administration & dosage | Acute respiratory distress syndrome | Evaluation | Hypoxia | Prostacyclin | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Thoracic and Cardiovascular Surgery, ISSN 0022-5223, 04/2004, Volume 127, Issue 4, pp. 1058 - 1067
Background: The purpose of this study was to describe our institutional experience in using inhaled prostacyclin as a selective pulmonary vasodilator in... 
SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | PGI2 | EPOPROSTENOL | PLATELET-FUNCTION | RESPIRATORY-DISTRESS-SYNDROME | TRANSPLANTATION | RESPIRATORY SYSTEM | CARDIAC-SURGERY | NITRIC-OXIDE | AEROSOLIZED PROSTACYCLIN | PROSTAGLANDIN | VASOCONSTRICTION | Bronchodilator Agents - therapeutic use | Prospective Studies | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Hypoxia - mortality | Male | Nitric Oxide - therapeutic use | Hypoxia - therapy | Positive-Pressure Respiration | Hypertension, Pulmonary - therapy | Epoprostenol - therapeutic use | Cardiac Surgical Procedures | Adult | Female | Blood Pressure - drug effects | Epoprostenol - economics | Vasodilator Agents - economics | Antihypertensive Agents - economics | Ventricular Dysfunction, Right - therapy | Bronchodilator Agents - economics | Hypertension, Pulmonary - mortality | Administration, Inhalation | Treatment Outcome | Antihypertensive Agents - therapeutic use | Ventricular Dysfunction, Right - mortality | Nitric Oxide - economics | Ventilation-Perfusion Ratio - drug effects | Survival Analysis | Aged | Cost Savings - economics | Medical colleges | Hypoxia | Care and treatment | Prostacyclin | Vasodilators | Pulmonary hypertension | Complications and side effects | Medical research | Nitric oxide | Medicine, Experimental | Index Medicus | Abridged Index Medicus
Journal Article